semaglutide podcast Republic In the rapidly evolving GLP-1

As soon as January 2026, companies like Sandoz and Apotex are expected to launch generic versions of semaglutide in Canada, where protections from data exclusivity will come to an end

Consumers should factor these disclosures into how they interpret testimonial-based claims on the website

provider or insurance

I know many women who dont need to lose weight for health reasons but wonder if they should give GLP-1s a shotand of course, some content creators are feeling the pull too

doi:10.1523/JNEUROSCI.0175-20.2020

Protein can also provide a sense of fullness, which will become more important as you transition off your GLP-1 treatment